No abstract

The ER chaperone GRP78/BiP is crucial for the development of rheumatoid arthritis.

Autophagy is a critical regulator of cellular homeostasis, dysregulation of which is associated with diverse diseases. Here we show therapeutic effects of a novel autophagy enhancer identified by high-throughput screening of a chemical library against metabolic syndrome. An autophagy enhancer increases LC3-I to LC3-II conversion without mTOR inhibition. MSL, an autophagy enhancer, activates calcineurin, and induces dephosphorylation/nuclear translocation of transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy gene expression. MSL accelerates intracellular lipid clearance, which is reversed by lalistat 2 or Tfeb knockout. Its administration improves the metabolic profile of ob/ob mice and ameliorates inflammasome activation. A chemically modified MSL with increased microsomal stability improves the glucose profile not only of ob/ob mice but also of mice with diet-induced obesity. Our data indicate that our novel autophagy enhancer could be a new drug candidate for diabetes or metabolic syndrome with lipid overload.

Background:The proinflammatory adipokine lipocalin-2 is associated with obesity-related complications, such as heart failure. Results: Lipocalin-2 induces cardiomyocyte apoptosis via elevating intracellular iron levels and mediates detrimental effects on cardiac function. Conclusion: Lipocalin-2 is an important mediator of cardiac remodeling. Significance: Regulation of cardiomyocyte apoptosis by lipocalin-2, and the mechanistic role of changes in intracellular iron, may contribute to the pathogenesis of obesity-related heart failure.

This work describes bipolar 2,5-diaryl-1,3,4-oxadiazole-fluorene hybrids which incorporate triphenylamine or carbazole units within the p-electron system, viz. compounds 7, 8, 14 and 16. A related bipolar bis(oxadiazolyl)pyridine system 20 is reported. The syntheses of these five new materials are discussed, along with their optoelectronic absorption and emission properties, and their solution electrochemical redox properties. Anodic electropolymerisation of 20 was observed. Calculations using DFT (density functional theory) establish that they all possess a significantly higher HOMO energy level (by 0.60-1.02 eV) than 1,3-bis[2-(4-tert-butylphenyl)-1,3,4-oxadiazol-5-yl]benzene (OXD-7) due to the presence of electron-rich amine moieties and increased conjugation lengths, thereby leading to more balanced charge-transport characteristics. Devices were fabricated by spin-coating techniques using the bipolar compounds as the emitters in the simple device architecture ITO:PEDOT-PSS:X:Ca/Al (X = 7, 8, 14, 16 or 20). The turn-on voltages were 2.9, 5.5, 3.6, 4.5 and 3.4 V for the devices incorporating 7, 8, 14, 16 and 20, respectively. The highest external quantum efficiency (EQE) was observed for compound 7: viz. EQE 0.36%; current efficiency 1.00 cd A 21 ; power efficiency 0.56 lm W 21 at 5.7 V. The EQE of the device fabricated from 8 was considerably lower than for devices using other materials due to low light emission. The EL emission peaked at l max 430, 487, 487 and 521 nm for 8, 14 and 16, and 7, respectively. For the 20 device l max = 521 nm and 564 nm. Thus the HOMO-LUMO gap has been modified, allowing the colour of the emitted light to vary from light blue through to green by the systematic chemical modification of the molecular subunits. The high chemical and thermal durability of these materials combined with the simplicity of the device structure and low turn-on voltages offers considerable potential for OLED applications.